A high level of Hsp70 was found in patients with acute myeloid leukemia, breast cancer, endometrial carcinoma, colorectal adenocarcinoma and was correlated with a decreased overall survival [7–10]. This evidence concerns the gene HSPA1A and breast carcinoma.